SG Americas Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.8M | Buy |
199,705
+63,681
| +47% | +$11.1M | 0.04% | 346 |
|
|
2025
Q4 | $23.1M | Buy |
136,024
+131,592
| +2,969% | +$20.2M | 0.03% | 454 |
|
|
2025
Q3 | $584K | Buy |
4,432
+884
| +25% | +$106K | ﹤0.01% | 1986 |
|
|
2025
Q2 | $377K | Sell |
3,548
-5,897
| -62% | -$641K | ﹤0.01% | 1846 |
|
|
2025
Q1 | $1.17M | Buy |
+9,445
| New | +$1.23M | ﹤0.01% | 1058 |
|
|
2024
Q4 | – | Sell |
-6,751
| Closed | -$752K | – | 3361 |
|
|
2024
Q3 | $752K | Buy |
+6,751
| New | +$740K | ﹤0.01% | 1326 |
|
|
2024
Q2 | – | Sell |
-19,472
| Closed | -$2.35M | – | 3070 |
|
|
2024
Q1 | $2.35M | Sell |
19,472
-39,137
| -67% | -$4.79M | 0.01% | 815 |
|
|
2023
Q4 | $7.21M | Buy |
58,609
+53,888
| +1,141% | +$6.72M | 0.07% | 265 |
|
|
2023
Q3 | $611K | Buy |
+4,721
| New | +$629K | 0.01% | 1613 |
|
|
2023
Q2 | – | Sell |
-5,668
| Closed | -$829K | – | 2721 |
|
|
2023
Q1 | $829K | Sell |
5,668
-2,067
| -27% | -$306K | 0.01% | 1283 |
|
|
2022
Q4 | $1.23M | Sell |
7,735
-67
| -0.9% | -$9.82K | 0.02% | 837 |
|
|
2022
Q3 | $1.04M | Sell |
7,802
-1,447
| -16% | -$220K | 0.01% | 992 |
|
|
2022
Q2 | $1.44M | Sell |
9,249
-15,270
| -62% | -$2.35M | 0.02% | 981 |
|
|
2022
Q1 | $3.82M | Buy |
24,519
+19,002
| +344% | +$2.76M | 0.03% | 552 |
|
|
2021
Q4 | $703K | Buy |
5,517
+737
| +15% | +$96.9K | ﹤0.01% | 1903 |
|
|
2021
Q3 | $622K | Sell |
4,780
-6,355
| -57% | -$960K | ﹤0.01% | 2320 |
|
|
2021
Q2 | $1.98M | Sell |
11,135
-776
| -7% | -$134K | 0.01% | 1132 |
|
|
2021
Q1 | $1.96M | Sell |
11,911
-24,105
| -67% | -$3.97M | 0.01% | 1053 |
|
|
2020
Q4 | $5.94M | Buy |
36,016
+21,971
| +156% | +$3.27M | 0.03% | 422 |
|
|
2020
Q3 | $2M | Buy |
14,045
+9,292
| +195% | +$1.15M | 0.01% | 742 |
|
|
2020
Q2 | $524K | Buy |
4,753
+663
| +16% | +$73.3K | ﹤0.01% | 2054 |
|
|
2020
Q1 | $408K | Buy |
+4,090
| New | +$529K | ﹤0.01% | 2000 |
|
|
2019
Q4 | – | Sell |
-6,800
| Closed | -$871K | – | 3361 |
|
|
2019
Q3 | $871K | Buy |
6,800
+3,111
| +84% | +$417K | 0.01% | 1483 |
|
|
2019
Q2 | $526K | Sell |
3,689
-41,243
| -92% | -$5.54M | ﹤0.01% | 1859 |
|
|
2019
Q1 | $6.42M | Buy |
+44,932
| New | +$5.86M | 0.06% | 322 |
|
|
2018
Q4 | – | Sell |
-7,949
| Closed | -$1.34M | – | 3194 |
|
|
2018
Q3 | $1.34M | Buy |
7,949
+5,965
| +301% | +$1.03M | 0.01% | 1476 |
|
|
2018
Q2 | $342K | Sell |
1,984
-5,815
| -75% | -$950K | ﹤0.01% | 2270 |
|
|
2018
Q1 | $1.18M | Buy |
+7,799
| New | +$1.14M | 0.01% | 1221 |
|
|
2017
Q4 | – | Sell |
-1,383
| Closed | -$202K | – | 3427 |
|
|
2017
Q3 | $202K | Sell |
1,383
-1
| -0.1% | -$151 | ﹤0.01% | 2578 |
|
|
2017
Q2 | $215K | Buy |
1,384
+159
| +13% | +$24.3K | ﹤0.01% | 2378 |
|
|
2017
Q1 | $178K | Sell |
1,225
-28,416
| -96% | -$3.7M | ﹤0.01% | 2530 |
|
|
2016
Q4 | $3.23M | Buy |
29,641
+28,293
| +2,099% | +$3.15M | 0.03% | 666 |
|
|
2016
Q3 | $164K | Sell |
1,348
-3,345
| -71% | -$451K | ﹤0.01% | 2653 |
|
|
2016
Q2 | $663K | Buy |
4,693
+282
| +6% | +$41.6K | ﹤0.01% | 1553 |
|
|
2016
Q1 | $576K | Buy |
4,411
+3,277
| +289% | +$408K | ﹤0.01% | 1671 |
|
|
2015
Q4 | $159K | Sell |
1,134
-4,443
| -80% | -$616K | ﹤0.01% | 2209 |
|
|
2015
Q3 | $741K | Sell |
5,577
-4,085
| -42% | -$703K | ﹤0.01% | 952 |
|
|
2015
Q2 | $1.7M | Buy |
9,662
+5,039
| +109% | +$905K | 0.01% | 791 |
|
|
2015
Q1 | $799K | Sell |
4,623
-16,066
| -78% | -$2.76M | ﹤0.01% | 1242 |
|
|
2014
Q4 | $3.39M | Buy |
20,689
+15,261
| +281% | +$2.53M | 0.02% | 759 |
|
|
2014
Q3 | $872K | Buy |
5,428
+2,656
| +96% | +$408K | 0.01% | 1210 |
|
|
2014
Q2 | $408K | Sell |
2,772
-4,328
| -61% | -$600K | ﹤0.01% | 1754 |
|
|
2014
Q1 | $985K | Buy |
7,100
+5,930
| +507% | +$893K | ﹤0.01% | 1146 |
|
|
2013
Q4 | $148K | Sell |
1,170
-1,476
| -56% | -$153K | ﹤0.01% | 2197 |
|
|
2013
Q3 | $243K | Buy |
+2,646
| New | +$213K | ﹤0.01% | 2048 |
|
Other funds holding JAZZ
VPM
VCM
EC
SG Americas Securities's JAZZ Position: Q1 2026 in Review
SG Americas Securities increased its Jazz Pharmaceuticals (JAZZ) stake by 47% in Q1 2026, buying an estimated $11.1M and bringing the position to 199,705 shares worth $37.8M. The position accounts for 0.04% of the portfolio, ranked #346.
SG Americas Securities first reported a position in JAZZ in Q3 2013 and has held it in 45 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- SG Americas Securities held 199,705 shares of Jazz Pharmaceuticals worth $37.8M as of Q1 2026.
- SG Americas Securities bought 63,681 Jazz Pharmaceuticals shares in Q1 2026, an estimated $11.1M.
- Jazz Pharmaceuticals made up 0.04% of SG Americas Securities's portfolio in Q1 2026, its #346 holding.
- SG Americas Securities first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 45 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.